SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Cannabis stocks, including TLRY, are surging amid reports that President Trump is considering executive action to ease federal marijuana restrictions, sparking excitement among investors and prompting discussions about a potential short squeeze. The community is actively debating the potential impact of rescheduling, with some focusing on US multi-state operators while others eye Canadian LPs. Speculation is high regarding potential price targets, short covering, and the possibility of a multi-day squeeze.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom's stock is seeing volatility following earnings, with initial excitement over better-than-expected results and AI chip sales guidance giving way to profit-taking. Community discussions revolve around the sustainability of Broadcom's valuation and the impact of AI revenue margins, with some analysts updating their target prices. Despite a recent pullback, the overall sentiment suggests strong underlying demand for Broadcom's AI-related products.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members highlight its roots in cannabis culture and its presence on the Solana blockchain. Many are drawn to its positioning as a 'culture coin' with a focus on creativity and community building. Comparisons to Bitcoin are frequent, with the community emphasizing a vision of going 'way higher'.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors eagerly anticipate its Autonomy and AI Day, where the company is expected to showcase advancements in self-driving technology and AI integration. Community members are debating Rivian's strategy to develop its own chips and lidar technology, questioning its potential impact on profitability and competition with established players like Tesla and Nvidia. Bullish sentiment remains strong among long-term investors, who see Rivian as a potential leader in the EV market, while bears express concerns about cash flow and execution.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors discuss the potential impact of a move to the Nasdaq exchange and speculate about upcoming OEM partnerships, particularly with the inauguration of the Eagle Line facility approaching in February 2026. Community chatter also revolves around the company's technology, its scaling roadmap, and anticipated announcements. Bullish investors express confidence in QuantumScape's long-term potential and its positioning in the solid-state battery market.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending following a Q3 earnings beat, boosted full-year guidance, and the announcement of a CEO succession plan, with an additional buyback authorization. Community discussions highlight confidence in the company's strong execution and long-term prospects, with some anticipating analyst upgrades. Some are also discussing the company's international business and China sales.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as aerospace sector momentum builds, with potential tailwinds from a SpaceX IPO and growing interest in space-based data centers. Community members highlight the company's solid execution, recent funding, and upcoming Neutron launch as key catalysts. Discussions also revolve around technical analysis, potential price targets, and the debate between long-term potential versus short-term pullbacks.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

GLSI is trending due to anticipation surrounding an upcoming presentation and speculation about potential news, possibly at the SABCS conference. Community members are focused on the high short borrow rate and the possibility of a short squeeze, with some expressing FOMO and discussing technical indicators. The overall sentiment suggests a belief in the company's long-term potential, particularly regarding its breast cancer treatment.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as community members discuss its potential for institutional adoption and compare it to other blockchains like Keeta. Mentions of JPMorgan using Solana for a debt deal and speculation around a potential XRP partnership are circulating. The community is also actively discussing various Solana-based meme coins, including WEEDCOIN, PMV, and WAGMI.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF ($IWM) is trending as it flirts with new all-time highs, signaling a potential breakout and small-cap rally. Community discussions revolve around sector rotation, identifying undervalued small-cap setups, and hedging strategies in anticipation of the upcoming Fed meeting and potential market volatility. Bullish sentiment is fueled by rate cut expectations and positive technical indicators, while concerns linger about unprofitable companies and overbought conditions.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data

TRIB's needle-free CGM+ sensor shows accurate 15-day results with no calibration, slashing costs and boosting access.

Trinity Biotech&nbsp;notched its best session on record on Thursday after its New York reference laboratory received approval from the New York State Department of Health to begin offering the FDA-cleared PreClara Ratio biomarker test for assessing the risk of preeclampsia.&nbsp;Shares of Trinity Biotech soared 89.1% to $1.9 on Thursday, marking its best session since the company’s launch in 1992, before sliding 16% to $1.6 in after-hours trading. Additionally, trading volume in Trinity surged to 208.5 million shares on Thursday, more than 1,160 times its average daily volume of 178,948.The service, which has a planned release in the third quarter (Q3) of 2025, is expected to support clinicians in making more rapid and informed decisions for patients hospitalized with hypertensive disorders of pregnancy, a complex set of conditions that impacts approximately 500,000 women annually in the U.S.&nbsp;The test, by estimating the risk of progression to severe preeclampsia, can enable earlier and more precise interventions.&nbsp;Research published in March estimated the potential to achieve more than $10 million in neonatal cost savings per 1,000 patients with the test as part of standard care, largely due to a reduction in preterm births and NICU days.The approval also paves the way for Trinity's expected launch of PrePsia, its proprietary technology that screens for preeclampsia risk earlier in pregnancy.&nbsp;Preeclampsia is estimated to affect 5–8% of pregnancies. The condition is a major driver of maternal and neonatal complications in the U.S., accounting for approximately 11% of maternal deaths and 15% of premature births.The PreClara Ratio is designed for use alongside other laboratory tests and clinical assessments in women between 23 and nearly 35 weeks of pregnancy who are hospitalized with hypertensive disorders.&nbsp;It calculates a ratio from specific blood test results to estimate the short-term risk of developing severe preeclampsia.On Stocktwits, retail sentiment for Trinity Biotech was ‘extremely bullish’ amid a 7,211% surge in 24-hour message volume.One user remarked that they expected Trinity Biotech to climb back over $3.00 the next day, urging others to “buy the dips and hold,” adding that all short shares were accounted for and the stock “can rip and halt like it did today.”&nbsp;<stembedurl>https://stocktwits.com/Magicians/message/625281470</stembedurl>Another user speculated that the sharp rise could be followed by a dilution announcement, noting the stock was now “going down on huge volume.”&nbsp;<stembedurl>https://stocktwits.com/Huskersnsaints/message/625247540</stembedurl>A third user predicted it could “easily break $4.00” going into the next session, recommending buying at market price and holding.<stembedurl>https://stocktwits.com/Magicians/message/625225289</stembedurl>Trinity Biotech’s stock has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of Trinity Biotech (TRIB) soared 89.1% to $1.9 on Thursday, marking its best session since the company’s launch in 1992. (Photo credit: Getty Images)

Trinity Biotech Stock Marks Best Day Ever On New York Greenlight For Pregnancy Risk Test; Retail Sees More Upside

Trading volume in Trinity Biotech spiked to more than 1,160 times its daily average after regulators cleared the PreClara Ratio test, which helps doctors identify pregnant patients at risk of developing severe preeclampsia.

Equity

Three nano-cap healthcare stocks drew massive attention from retail investors on Stocktwits Tuesday, though not all for positive reasons.Trinity Biotech (<a href="https://stocktwits.com/symbol/TRIB">TRIB</a>)&nbsp;Shares of the medical diagnostic products maker saw a staggering 15,550% jump in retail message volume after the company released “compelling” results from a study on its next-generation continuous glucose monitoring system.&nbsp;The device, designed for real-time diabetes management, demonstrated superior signal quality, accuracy, and consistency in a trial involving 30 diabetic participants.&nbsp;The system features a reusable applicator and rechargeable wearable transmitter, reducing costs by eliminating disposable components.&nbsp;Trinity said it remains on track to seek regulatory approval in the EU by 2025 and the U.S. by 2026.&nbsp;Shares fell over 13% premarket Wednesday.Silexion Therapeutics (<a href="https://stocktwits.com/symbol/SLXN">SLXN</a>)&nbsp;The cancer-focused biotech firm’s ticker saw a 9,060% surge in retail message volume as its stock more than doubled Tuesday following promising preclinical data for its tumor drug candidate SIL-204.&nbsp;The company reported that the extended-release formulation of SIL-204 reduced tumor growth by more than 50% after 30 days, with around 50% of tumors showing complete necrosis in human pancreatic models.&nbsp;Additionally, an injectable version of the drug candidate showed tumor growth inhibition in metastatic pancreatic mouse models.&nbsp;The stock continued its rally, gaining over 70% premarket Wednesday.Sharps Technology (<a href="https://stocktwits.com/symbol/STSS">STSS</a>)&nbsp;The medical packaging firm experienced a 6,233% surge in retail message volume, but for the wrong reasons.&nbsp;Shares plunged nearly 70% to a record low on Tuesday after the company announced a $20 million public offering of 14,285,714 Common Units.&nbsp;Each unit consists of one share of common stock, one Series A warrant, and one Series B warrant, priced at $1.40 per unit, a 4.1% discount to Monday’s close.&nbsp;The company said the proceeds would be used for general corporate purposes and working capital.&nbsp;The stock continued to slide, down over 2% premarket Wednesday.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%

“Compelling” results from a study, promising pre-clinical data and a public offering got Stocktwits investors buzzing on Tuesday.

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Trinity Biotech Plc - ADR

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

TRIB
Trinity Biotech plc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest TRIB News

TRIBTrinity Biotech plc